Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flecainide 40mg/5ml oral liquid
0203020I0AABCBC
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 4mg/5ml oral liquid
0203020I0AABPBP
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 50mg/5ml oral liquid
0203020I0AAAQAQ
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 5mg/5ml oral liquid
0203020I0AAARAR
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 60mg/5ml oral liquid
0203020I0AABJBJ
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 65mg/5ml oral liquid
0203020I0AABGBG
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 6mg/5ml oral liquid
0203020I0AABDBD
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 80mg/5ml oral liquid
0203020I0AABEBE
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.